Recital 3, Regulation (EU) 2026/2024

In forcesince 10 Sep 2026

On 24 July 2025, Lanxess Deutschland GmbH submitted to the European Chemicals Agency (‘the Agency’), in accordance with Article 12(1) of Implementing Regulation (EU) No 354/2013, an application for minor changes to the Union authorisation for the biocidal product family ‘LANXESS CMIT/MIT biocidal product family’, as referred to in Title 2 of the Annex to that Regulation. The application was recorded in the Register for Biocidal Products under case number BC-HT109132-36. The proposed changes to that authorisation concern the extension of the shelf life of products in meta-SPC 1 to 6.